🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy of once daily dosing with SPARC's novel ophthalmic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06-10
Trial ID
NCT03927443
This study will evaluate the skin pharmacokinetics and tolerability of bima...
Status
Completed
Location
DermResearch, LLC
Start Date
2016-07
Trial ID
NCT02848300
Treatments Being Tested
A study to evaluate patient satisfaction, aesthetic and psychological impac...
Status
Completed
Location
Multiple Locations
Start Date
2014-06-30
Trial ID
NCT02176356
This study will assess the efficacy, safety, tolerability and persistence o...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01489670
Treatments Being Tested
A prospective, parallel-group, double-blind, randomized placebo-controlled ...
Status
Unknown
Location
University of Puerto Rico, Medical Sciences Campus
Start Date
2020-05-15
Trial ID
NCT04380025
Treatments Being Tested
The purpose of this research is to treat vitiligo with a topical PGF2α, mic...
Status
Completed
Location
Medical University of South Carolina
Start Date
2021-11-02
Trial ID
NCT04738149
Treatments Being Tested
Vitiligo is an acquired depigmentation disorder of great cosmetic importanc...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01202513
Treatments Being Tested
The purpose of this study was to assess the efficacy and tolerability of ch...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01327599
Treatments Being Tested
This study will evaluate the long-term safety of bimatoprost 0.01% ophthalm...
Status
Completed
Location
UZ Leuven
Start Date
2011-05-31
Trial ID
NCT01298700
Treatments Being Tested
This study will evaluate the safety and efficacy of 3 doses of bimatoprost ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01325337